Strong evidence for LncRNA ZNRD1-AS1, and its functional Cis- eQTL locus contributing more to the susceptibility of lung cancer

Oncotarget

Volumn 7, Issue 24, 2016, Pages 35813-35817

  Li, Dan ^a   Song, Lei ^a   Wen, Zhongmei ^a   Li, Xiaoping ^a   Jie, Jing ^a   Wang, Yan ^a   Peng, Liping ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

LncRNA; Lung cancer; SNP; Susceptibility; ZNRD1 AS1

Indexed keywords

LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA ZNRD1; LONG UNTRANSLATED RNA ZNRD1 AS1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HLA ANTIGEN CLASS 1; ZNRD1 PROTEIN, HUMAN; ZNRD1AS GENE PRODUCT, HUMAN;

ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHINESE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; LUNG CANCER; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNOLOGY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; LUNG TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, LONG NONCODING;

EID: 84978035374     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8411     Document Type: Article

References (19)

1. Zhao Y, Hong L, Wang R, Fan D. Expression and prognostic value of ZNRD1 in esophageal squamous cell carcinoma. Dig Dis Sci. 2009; 54:586-592
2. Guo W, Zhao YP, Jiang YG, Wang RW, Hong L, Fan DM. ZNRD1 might mediate UV irradiation related DNA damage and repair in human esophageal cancer cells by regulation of ERCC1. Dis Esophagus. 2008; 21:730-736
3. Hong L, Piao Y, Han Y, Wang J, Zhang X, Du Y, Cao S, Qiao T, Chen Z, Fan D. Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2. Mol Cancer Ther. 2005; 4:1936-1942
4. Zhang YM, Zhao YQ, Pan YL, Shi YQ, Jin XH, Yi H, Fan DM. Effect of ZNRD1 gene antisense RNA on drug resistant gastric cancer cells. World J Gastroenterol. 2003; 9:894-898
5. Ding F, Xin DQ, Pan BN. [Expression of ZNRD1 protein in human renal cell carcinoma]. Zhonghua Zhong Liu Za Zhi. 2008; 30:821-824
6. Guo L, Wen J, Han J, Jiang J, Xie S, Feng X, Wei B, Dai J, Zhang K, Qi J, Ma H, Shi J, Ren J, et al. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence cervical cancer development. Am J Cancer Res. 2015; 5:2301-2307
7. Wen J, Liu Y, Liu J, Liu L, Song C, Han J, Zhu L, Wang C, Chen J, Zhai X, Shen H, Hu Z. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development. Mol Carcinog. 2015; 54:1275-1282
8. Shang Y, Zhang Z, Liu Z, Feng B, Ren G, Li K, Zhou L, Sun Y, Li M, Zhou J, An Y, Wu K, Nie Y, Fan D. miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1. Oncogene. 2014; 33:3267-3276
9. Li J, Han L, Roebuck P, Diao L, Liu L, Yuan Y, Weinstein JN, Liang H. TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. Cancer Res. 2015; 75:3728-3737
10. Zhao W, An Y, Liang Y, Xie XW. Role of HOTAIR long noncoding RNA in metastatic progression of lung cancer. Eur Rev Med Pharmaco. 2014; 18:1930-1936
11. Hong L, Zhang Y, Liu N, Liu C, Zhi M, Pan Y, Lan M, Sun L, Fan D. Suppression of the cell proliferation in stomach cancer cells by the ZNRD1 gene. Biochem Biophys Res Commun. 2004; 321:611-616
12. Middleton D, Vilchez JR, Cabrera T, Meenagh A, Williams F, Halfpenny I, Maleno I, Ruiz-Cabello F, Lopez-Nevot MA, Garrido F. Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours. Tissue Antigens. 2007; 69:220-226
13. El-Chennawi FA, Auf FA, El-Diasty AM, El-Daim MA, El-Sherbiny SM, Ali A, El-Baz M, El-Hameed MA, Paul P, Ibrahim EC, Carosella E, Ghoneim MA. Expression of HLA-G in cancer bladder. Egyp J Imm. 2005; 12:57-64
14. Maleno I, Romero JM, Cabrera T, Paco L, Aptsiauri N, Cozar JM, Tallada M, Lopez-Nevot MA, Garrido F. LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas. Immunogenetics. 2006; 58:503-510
15. Braf ZF, Gazit E, Many M. HLA-A and HLA-B antigens in transitional cell carcinoma of the bladder. J Urol. 1979; 122:465-466
16. Zhao F, Lin T, He W, Han J, Zhu D, Hu K, Li W, Zheng Z, Huang J, Xie W. Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer. Oncotarget. 2015; 6:1064-1078. doi: 10.18632/oncotarget.2833
17. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010; 329:689-693
18. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010; 464:1071-1076
19. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, Cherry JM, Snyder M. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012; 22:1790-1797